Patents by Inventor Richard E. Randall

Richard E. Randall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sound damping wallboard and method of forming a sound damping wallboard
    Patent number: 11939765
    Abstract: A sound damping wallboard and methods of forming a sound damping wallboard are disclosed. The sound damping wallboard comprises a gypsum layer with a gypsum surface having an encasing layer. The encasing layer is partially removed to expose the gypsum surface and form a gypsum surface portion and a first encasing layer portion on the gypsum layer. A sound damping layer is applied to the gypsum layer to cover at least part of the gypsum surface portion and the encasing layer portion.
    Type: Grant
    Filed: December 5, 2022
    Date of Patent: March 26, 2024
    Assignee: Gold Bond Building Products, LLC
    Inventors: Michael N. Blades, John M. Watt, John E. Yakowenko, Todd D. Broud, Keith R. O'Leary, Stephen A. Cusa, Mauricio Quiros, Brian G. Randall, Richard P. Weir
  • Adjuvants
    Patent number: 11406704
    Abstract: The present disclosure provides novel adjuvants which may be used in combination with one or more antigens to augment, modulate or enhance a host immune response to the one or more antigens. The adjuvants are based on sialic acid binding molecules and may be combined with any type of antigen. The adjuvants may be formulated for mucosal and/or intranasal administration.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: August 9, 2022
    Assignee: PNEUMAGEN LIMITED
    Inventors: Helen Connaris, Garry Taylor, Richard E. Randall
  • NOVEL ADJUVANTS
    Publication number: 20190224311
    Abstract: The present disclosure provides novel adjuvants which may be used in combination with one or more antigens to augment, modulate or enhance a host immune response to the one or more antigens. The adjuvants are based on sialic acid binding molecules and may be combined with any type of antigen. The adjuvants may be formulated for mucosal and/or intranasal administration.
    Type: Application
    Filed: September 20, 2017
    Publication date: July 25, 2019
    Inventors: Helen Connaris, Garry Taylor, Richard E. Randall